Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2023-01-10 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
关于预计2023年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected related party transactions for the year 2023 by Guangdong Driving Force Biotechnology Group Co., Ltd. It includes details about the nature of the transactions, amounts, related parties, pricing policies, board approval, and opinions from the sponsor institution. The document is relatively short (2320 characters) and focuses on disclosure of anticipated related party transactions rather than presenting financial statements or comprehensive financial data. It is not an annual or interim report, audit report, or earnings release. It is also not a management change, voting result, or capital change announcement. The content fits best with a Regulatory Filing (RNS) as it is a regulatory disclosure about related party transactions without substantive financial statements or detailed financial analysis.
2023-01-10 Chinese
华安证券股份有限公司关于广东驱动力生物科技集团股份有限公司2023年日常性关联交易预计的专项核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed opinion from a sponsoring securities company regarding the expected related party transactions for the year 2023 of Guangdong Driving Force Biotechnology Group Co., Ltd. It includes descriptions of the related parties, transaction amounts, pricing policies, internal approval procedures, and the sponsor's verification opinion. The document is not a financial report like an annual or interim report, nor is it a brief announcement or voting result. It is a specialized report on related party transactions and the sponsor's review, which fits best under Regulatory Filings (RNS) as it does not match other specific categories such as Annual Report, Audit Report, or Capital Update. The document length is under 5,000 characters and contains substantive content, not just a notice or certification, so it is not RPA or a certification. Therefore, the best classification is Regulatory Filings (RNS).
2023-01-10 Chinese
第三届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of Guangdong Drive Biological Technology Group Co., Ltd. It details the convening, attendance, and resolutions passed during the ninth meeting of the third Supervisory Board. The content includes procedural details, voting results, and compliance statements. There is no financial data, audit information, or detailed report content. It is not an annual report, audit report, earnings release, or any financial report. It is also not a regulatory filing or certification. The document is a formal announcement of a board meeting resolution, which fits best under Board/Management Information (MANG) as it relates to company governance and board activities.
2023-01-10 Chinese
关于公司入选广东省2022年创新型中小企业的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (587 characters) about the company being selected as an innovative SME by a provincial government department. It contains no financial data, no detailed report, no management or board changes, no voting results, no legal proceedings, no capital or financing updates, and no earnings information. It is a regulatory announcement about a recognition or award, not a report or detailed filing. The document is brief and informational, fitting best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2022-12-12 Chinese
关于公司参与起草的健康瘦肉型猪血红蛋白浓度标准团体标准获批发布的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (869 characters) about the approval and publication of a group standard related to the company's product. It includes a notice from a regulatory or standards body and discusses the impact on the company, but it does not contain any financial data, detailed financial results, or management discussion. It is not a report itself but an announcement of a standard approval. The document also includes a risk warning to investors but no financial statements or detailed analysis. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous announcements that do not fit other specific categories.
2022-11-23 Chinese
2022年第三季度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the implementation of the 2022 third quarter equity distribution (权益分派实施公告) by Guangdong Drive Biological Technology Group Co., Ltd. It details the dividend distribution plan, including the cash dividend amount, the base date for equity registration, the ex-dividend date, tax withholding policies, and the method of dividend payment. The document does not contain comprehensive financial statements or detailed financial performance data but focuses on the dividend distribution specifics. The document length is 1896 characters, which is relatively short and focused on dividend distribution details. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. Therefore, the correct classification is DIV with high confidence.
2022-11-17 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.